Opticross
Payments companies reported to CMS as associated with Opticross. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Opticross, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Opticross
These are the largest totals companies reported as associated with Opticross. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Damian Grovas Abad | San Juan, PR | Interventional Cardiology | $16,021.24 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $10,150.00 |
| Ryan Madder | Royal Oak, MI | Interventional Cardiology | $3,125.00 |
| Tarek Hammad | San Antonio, TX | Hospitalist | $2,687.71 |
| Anvar Babaev | New York, NY | Interventional Cardiology | $2,630.32 |
| Michael Attubato | New York, NY | Interventional Cardiology | $2,524.65 |
| Alexander Slotwiner | New York, NY | Interventional Cardiology | $2,500.00 |
| Hayder Hashim | Washington, DC | Cardiovascular Disease | $2,362.53 |
| Joaquim Spadoni Barboza | Evergreen Park, IL | Internal Medicine | $2,247.10 |
| Sanjog Kalra | Philadelphia, PA | Interventional Cardiology | $1,750.00 |
Prescribed Opticross?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.